Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

During the Trading Day
111.12 +0.21 / +0.19%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
111.12 0.00 / 0.00%
 
Volume: 2.4K
Will ARIAD (ARIA) Disappoint Estimates this Earnings Season? - Analyst Blog
4:17pm / Zacks.com
Why MedAssets (MDAS) is Surging after Q2 Earnings Results? - Analyst Blog
Aug 03 / Zacks.com
Is Agios (AGIO) Poised to Beat Estimates in Q2 Earnings? - Analyst Blog
1:16pm / Zacks.com
Will Cerner's (CERN) Earnings Pull a Surprise in Q2? - Analyst Blog
Jul 31 / Zacks.com
Outfront Media (OUT) to Report Earnings: What to Expect? - Analyst Blog
1:16pm / Zacks.com
Will BioMarin Top Q2 Earnings Again on Vimizim Sales? - Analyst Blog
Jul 31 / Zacks.com
3 MedTech Stocks to Buy Before Their Q2 Earnings - Earnings ESP
12:10pm / Zacks.com
Will DENTSPLY (XRAY) Beat Earnings on Pipeline Strength? - Analyst Blog
Jul 28 / Zacks.com
Community Health Q2 Earnings Beat, Surge Y/Y; View Revised - Analyst Blog
10:47am / Zacks.com
Can Cardinal Health's (CAH) Q4 Earnings Pull a Surprise? - Analyst Blog
Jul 28 / Zacks.com
Luminex (LMNX) Tops Q2 Earnings, Revenues; Pipeline Strong - Analyst Blog
10:30am / Zacks.com
Will Ecolab (ECL) Earnings Take Investors by Surprise in Q2? - Analyst Blog
Jul 24 / Zacks.com
Will Ligand Pharmaceuticals (LGND) Beat Earnings in Q2? - Analyst Blog
Aug 03 / Zacks.com
St. Jude to Acquire Thoratec for $3.4B: Potent Combination? - Analyst Blog
Jul 23 / Zacks.com
Will Isis Pharmaceuticals (ISIS) Beat Q2 Earnings Estimates? - Analyst Blog
Aug 03 / Zacks.com
XOMA Crashes after Gevokizumab Misses Primary Endpoint - Analyst Blog
Jul 23 / Zacks.com
Will Becton, Dickinson (BDX) Earnings Pull a Surprise in Q3? - Analyst Blog
Aug 03 / Zacks.com
Eli Lilly, Biogen Present Data at Alzheimer's Association - Analyst Blog
Jul 23 / Zacks.com